Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Verona Pharma Plc ADR (NASDAQ: VRNA) closed at $14.75 down -0.87% from its previous closing price of $14.88. In other words, the price has decreased by -$0.87 from its previous closing price. On the day, 0.73 million shares were traded. VRNA stock price reached its highest trading level at $15.26 during the session, while it also had its lowest trading level at $14.71.
Ratios:
For a deeper understanding of Verona Pharma Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 33.33 and its Current Ratio is at 33.33. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On August 26, 2022, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $31.Piper Sandler initiated its Overweight rating on August 26, 2022, with a $31 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 03 ’24 when Rickard Kathleen A. sold 36,248 shares for $1.96 per share. The transaction valued at 71,032 led to the insider holds 2,621,552 shares of the business.
Rickard Kathleen A. sold 36,248 shares of VRNA for $80,503 on Feb 05 ’24. The Chief Medical Officer now owns 2,731,624 shares after completing the transaction at $2.22 per share. On Nov 20 ’23, another insider, Edwards Martin, who serves as the Director of the company, bought 33,736 shares for $1.84 each. As a result, the insider paid 61,973 and bolstered with 144,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRNA now has a Market Capitalization of 1142332928 and an Enterprise Value of 9399847936.
Stock Price History:
Over the past 52 weeks, VRNA has reached a high of $23.81, while it has fallen to a 52-week low of $11.83. The 50-Day Moving Average of the stock is -8.21%, while the 200-Day Moving Average is calculated to be -11.39%.
Shares Statistics:
For the past three months, VRNA has traded an average of 445.89K shares per day and 452250 over the past ten days. A total of 80.44M shares are outstanding, with a floating share count of 59.93M. Insiders hold about 22.62% of the company’s shares, while institutions hold 63.62% stake in the company. Shares short for VRNA as of 1713139200 were 6067490 with a Short Ratio of 13.61, compared to 1710460800 on 6395065. Therefore, it implies a Short% of Shares Outstanding of 6067490 and a Short% of Float of 8.1999995.
